Association of Vaping and Respiratory Health among Youth in the Population Assessment of Tobacco and Health (PATH) Study Wave 3

Christie Cherian, Eugenia Buta, Patricia Simon, Ralitza Gueorguieva and Suchitra Krishnan-Sarin
Additional contact information
Christie Cherian: Pediatric Pulmonology, Yale School of Medicine, Yale University, New Haven, CT 06510, USA
Eugenia Buta: Yale Center for Analytical Sciences, Yale School of Public Health, Yale University, New Haven, CT 06510, USA
Patricia Simon: Department of Psychiatry, Yale School of Medicine, Yale University, New Haven, CT 06510, USA
Ralitza Gueorguieva: Department of Biostatistics, Yale School of Public Health, Yale University, New Haven, CT 06510, USA
Suchitra Krishnan-Sarin: Department of Psychiatry, Yale School of Medicine, Yale University, New Haven, CT 06510, USA

IJERPH, 2021, vol. 18, issue 15, 1-11

Abstract: The purpose of this study is to evaluate the association of electronic nicotine product (ENP) use and its respiratory manifestations in a nationally representative sample of adolescents in the US. Cross-sectional evidence from 9750 adolescents in wave 3 (October 2015–October 2016) of the Population Assessment of Tobacco and Health (PATH) survey was used. Adjusting for demographics, lifetime number of cigarettes and cigars used, home rules about tobacco use, and tobacco used by other household members, we used logistic regression models to examine associations between ENP use and its respiratory manifestations in the past year. Among 9750 adolescents, 12% ( n = 1105) used ENP in the past year. Compared to non-users, past-year ENP-users had 37% higher odds of wheezing in general (Adjusted Odds Ratio (AOR) = 1.37, 95% Confidence interval (CI): 1.11–1.71, p = 0.005) and higher odds of wheezing 4–12 times or >12 times per year versus no wheezing (AOR = 1.57, 95% CI: 1.01–2.46, p = 0.05 and AOR = 2.58, 95% CI: 1.04–6.41, p = 0.04, respectively). Additionally, odds of dry cough at night were 23% higher among ENP-users than among non-users (AOR = 1.23, 95% CI: 1.04–1.46, p = 0.02). There was no association between past-year ENP use and exercise-induced wheezing or asthma diagnosis. Among those with asthma, there was no evidence of an association between ENP use and long-acting inhaler or quick-relief inhaler use. ENP use among adolescents is associated with increased frequency of wheezing and dry cough. Early recognition of pulmonary clinical manifestations among young ENP users should be critical considerations in regulatory and prevention efforts to protect public health, and clinical efforts to prevent progression to serious pulmonary complications.

Keywords: electronic nicotine products (ENP); adolescents; pulmonary; wheezing; cough; public policy (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.mdpi.com/1660-4601/18/15/8208/pdf (application/pdf)
https://www.mdpi.com/1660-4601/18/15/8208/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:18:y:2021:i:15:p:8208-:d:607337

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().